Cargando…
LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance
Osteosarcoma (OS) is one of the most common primary solid malignant tumors in orthopedics, and its main clinical treatments are surgery and chemotherapy. However, a wide surgical resection range, functional reconstruction of postoperative limbs, and chemotherapy resistance remain as challenges for p...
Autores principales: | Xiaotong, Shi, Xiao, Li, Shiyu, Liao, Zhiguo, Bi, Chunyang, Feng, Jianguo, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885180/ https://www.ncbi.nlm.nih.gov/pubmed/36726721 http://dx.doi.org/10.3389/fgene.2022.1022155 |
Ejemplares similares
-
Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022) -
Newly discovered circRNAs encoding proteins: recent progress
por: Shi, Xiaotong, et al.
Publicado: (2023) -
N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022) -
Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma
por: Liu, Hua, et al.
Publicado: (2022) -
Dissecting the role of lactate metabolism LncRNAs in the progression and immune microenvironment of osteosarcoma
por: Huang, Liangkun, et al.
Publicado: (2023)